NCT00096993 2015-06-10A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube CancerGenentech, Inc.Phase 2 Completed131 enrolled 11 charts